Cornea keratitis

Eyes are especially susceptible to urticants. In addition to immediate pain, urticants produce lesions and inflammation to the cornea (keratitis), which may progress to blindness. 

The condition in which patients have a decreased vision, ocular pain, red eye, and often a cloudy/opaque cornea. Keratitis is mainly caused by bacteria, viruses, fungi, protozoa and parasites. 

ACUTE HEALTH RISKS eye irritation conjunctivitis discoloration of the conjunctiva and cornea keratitis skin irritation skin discoloration severe destruction to mucous membranes erythema swelling formation of papules and vesicles. 

These drugp possess anti-inflammatory activity and are used for inflammatory conditions, such as allergic conjunctivitis, keratitis, herpes zoster keratitis, and inflammation of the iris. Corticosteroids also may be used after injury to the cornea or after corneal transplants to prevent rejection. 

Figure 9.7 Mild anterior uveitis. Collections of macrophages (keratic precipitates) can be seen on the endothelial surface of the cornea (arrowheads).

Bacterial keratitis is a broad term for a bacterial infection of the cornea. This includes corneal ulcers and corneal abscesses. The cornea in a healthy eye has natural resistance to infection, making bacterial keratitis rare. However, many factors predispose a patient to bacterial infection by compromising the defense mechanisms of the eye (Table 60-5).19... 

Eyes are especially susceptible to vesicants. In addition to the immediate corrosive effects, the cornea of the eye can become inflamed (keratitis) after a latency of 6-10 years. This condition can progress to blindness. Corneal lesions may reoccur even after receiving a corneal transplantation. 

Inflammatory conditions Treatment of steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, lid, sclera, cornea, and anterior segment of the globe, such as Allergic conjunctivitis acne rosacea superficial punctate keratitis herpes zoster keratitis iritis cyclitis and selected infective conjunctivitis (when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation [prednisolone]) vernal conjunctivitis episcleritis epinephrine sensitivity and anterior uveitis. 

Acute epithelial herpes simplex keratitis (dendritic keratitis) fungal diseases of ocular structures vaccinia, varicella and most other viral diseases of the cornea and conjunctiva ocular tuberculosis hypersensitivity after uncomplicated removal of a superficial corneal foreign body mycobacterial eye infection acute, purulent, untreated eye infections that may be masked or enhanced by the presence of steroids. 

Infections Treatment of superficial ocular infections involving the conjunctiva or cornea (eg, conjunctivitis, keratitis, keratoconjunctivitis, corneal ulcers, blepharitis, blepharoconjunctivitis, acute meibomianitis, dacryocystitis) caused by strains of microorganisms susceptible to antibiotics. 

Efficacy In other conditions The clinical efficacy in the treatment of stromal keratitis and uveitis caused by herpes simplex or ophthalmic infections caused by vaccinia virus and adenovirus, or in the prophylaxis of herpes simplex virus keratoconjunctivitis and epithelial keratitis has not been established by well-controlled clinical trials. Not effective against bacterial, fungal, or chlamydial infections of the cornea or trophic lesions. 

Idoxuridine inhibits the replication of herpes simples virus in the cornea and is topically applied for herpetic keratitis. 

Infections of the external eye (the eyelids and conjunctiva or cornea) conjunctivitis, keratitis, corneal ulcer are distinguished from intra-ocular infections. The latter include infection of the vitreous (endoph-talmitis), uveitis and retinitis. Orbital and periorbital infections are often due to complications of sinusitis. 

Only solutions of lipophilic antibiotics are able to cross the external barrier of the cornea (drops) and the internal blood-retina barrier (systemic administration) to yield sufficient concentrations in the internal eye (vitreous). Keratitis and ulceration of the cornea can be treated by frequent administration of highly concentrated (fortified) antibiotic drops. In endophtalmitis, emergency vitreous aspirate and in-travitreal and subconjunctival injection of antibiotic solutions with a long half-life is the cornerstone of treatment. These solutions should be prepared by the hospital pharmacy. Empiric topical treatment of minor external eye infections consists of antibiotic containing gels or ointments. 

Ophthalmic (6%-l%) conjunctival irritation, reduced visual acuity, dry eye, keratitis, eye pain, ocular itching, swelling of tissue around cornea, eye discharge, fever, cough, pharyngifis, rash, rhinifis Rare (1 %)... 

A 47-year-old woman undergoing face peeling with 35% trichloroacetic acid developed left eye burning sensation, excessive tearing, marked conjunctival injection, conjunctival infection, and mild inferior superficial punctuate keratitis involving 25% of the cornea [32],... 

Herpetic keratitis. Inflammation of the cornea caused by a herpes virus. 

The third patient developed the infection after 1 month the keratitis cleared on withdrawal of latanoprost and antiviral therapy reinstitution of latanoprost with prophylactic antiviral medication (valaciclovir) kept the cornea clear, but as soon as the antiviral drug was discontinued, //. simplex virus keratitis reappeared. 

Frucht-Pery, J., et al. 2006. Iontophoretic treatment of experimental Pseudomonas keratitis in rabbit eye using gentamicin-loaded hydrogel. Cornea. In Press. 

Frucht-Perry, J., Assil, K. K., Ziegler, E., et al. (1992), Fibrin-enmeshed tobramycin liposomes Single application topical therapy of Pseudomonas keratitis, Cornea, 11, 393-397. 

Javadi, M., Yazdani, S., Kanavi, M., Mohammadpour, M., Baradaran-Rafiee, A., Jafarinasab, M., Einollahi, B., Karimian, F., Zare, M., Naderi, M., Rabei, H. (2007). Long-term outcomes of penetrating keratoplasty in chronic and delayed mustard gas keratitis. Cornea 26 1074-8. 

Ammonia or ammonium hydroxide can penetrate the cornea rapidly, leading to keratitis, damage of the iris, cataract, and glaucoma [1388]. 

When evaluating an acute injmy of the cornea, the practitioner is sometimes tempted to prescribe a topical anesthetic for administration at home by the patient for relief of ocular pain. This practice is extremely dangerous, however, and in numerous instances has led to severe infiltrative keratitis and even loss of the eye from anesthetic misuse or abuse by the patient.Topical anesthetics must be used only for the pmpose of obtaining initial relief of ocular pain and never as part of a prolonged therapeutic regimen.The potential corneal toxicity of topical anesthetics precludes their use as self-administered drugs. 

Borderie VM, Meritet J, Chaumeil C, et al. Culmre-proven herpetic keratitis after penetrating keratoplasty in patient with no previous history of herpes disease. Cornea 2004 23(2) 118-124. 

Kalavathy CM, Parmar P, Kahamurthy J, et al. Comparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitis. Cornea 2005 24(4) 449-452. 

Narasimhan S, Madhaven HN, Therese KL. Development and apphcation of an in vitro susceptibility test for Acanthamoeba species isolated from keratitis to polyhexamethylene biguanide and chlorhexidine. Cornea 2002 21(2) 203-205. 

Panda A, Sharma N,Angra SK, et al. Topical fluconazole therapy of Candida keratitis. Cornea 1996 5(4) 373-375. 

---